{"nct_id":"NCT00538915","title":"Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)","status":"COMPLETED","status_verified_date":"2012-02","start_date":"2007-09","start_date_type":null,"primary_completion_date":"2009-07","primary_completion_date_type":"ACTUAL","completion_date":"2009-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ADMA"]}